Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 7
2005 4
2006 5
2007 7
2008 1
2009 5
2010 7
2011 14
2012 13
2013 10
2014 18
2015 9
2016 14
2017 11
2018 8
2019 23
2020 25
2021 29
2022 14
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Pillars of long-term antiretroviral therapy success.
Taramasso L, Andreoni M, Antinori A, Bandera A, Bonfanti P, Bonora S, Borderi M, Castagna A, Cattelan AM, Celesia BM, Cicalini S, Cingolani A, Cossarizza A, D'Arminio Monforte A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Di Perri G, Esposito V, Focà E, Gervasoni C, Gori A, Gianotti N, Guaraldi G, Gulminetti R, Lo Caputo S, Madeddu G, Maggi P, Marandola G, Marchetti GC, Mastroianni CM, Mussini C, Perno CF, Rizzardini G, Rusconi S, Santoro M, Sarmati L, Zazzi M, Maggiolo F. Taramasso L, et al. Among authors: di giambenedetto s. Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28. Pharmacol Res. 2023. PMID: 37648103 Free article. Review.
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen.
Iannone V, Passerotto RA, Lamanna F, Steiner RJ, Lombardi F, Salvo PF, Dusina A, Farinacci D, Borghetti A, Di Giambenedetto S, Ciccullo A. Iannone V, et al. Among authors: di giambenedetto s. Viruses. 2023 Apr 25;15(5):1046. doi: 10.3390/v15051046. Viruses. 2023. PMID: 37243133 Free PMC article.
Dolutegravir plus lamivudine for the treatment of HIV-1 infection.
Ciccullo A, Baldin G, Borghetti A, Di Giambenedetto S. Ciccullo A, et al. Among authors: di giambenedetto s. Expert Rev Anti Infect Ther. 2020 Apr;18(4):279-292. doi: 10.1080/14787210.2020.1729742. Epub 2020 Feb 18. Expert Rev Anti Infect Ther. 2020. PMID: 32067525 Review.
Is smallpox vaccination protective against human monkeypox?
Moschese D, Farinacci D, Pozza G, Ciccullo A, Cossu MV, Giacomelli A, Borgonovo F, Mileto D, Santangelo R, Tamburrini E, Rizzardini G, Antinori S, Giambenedetto SD. Moschese D, et al. Among authors: giambenedetto sd. J Med Virol. 2023 Jan;95(1):e28077. doi: 10.1002/jmv.28077. Epub 2022 Sep 2. J Med Virol. 2023. PMID: 35993271 No abstract available.
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
Fabbiani M, Masini M, Rossetti B, Ciccullo A, Borghi V, Lagi F, Capetti A, Colafigli M, Panza F, Baldin G, Mussini C, Sterrantino G, Farinacci D, Montagnani F, Tumbarello M, Di Giambenedetto S. Fabbiani M, et al. Among authors: di giambenedetto s. Viruses. 2023 May 8;15(5):1123. doi: 10.3390/v15051123. Viruses. 2023. PMID: 37243208 Free PMC article.
Sexually transmitted infections in people with multidrug-resistant HIV.
Clemente T, Lolatto R, Papaioannu Borjesson R, Fabbiani M, Manzillo E, Fronti E, Di Giambenedetto S, Gagliardini R, Rusconi S, Santoro MM, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. Among authors: di giambenedetto s. AIDS. 2023 Dec 1;37(15):2425-2430. doi: 10.1097/QAD.0000000000003690. Epub 2023 Nov 16. AIDS. 2023. PMID: 37965740
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype.
Salvo PF, Farinacci D, Ciccullo A, Borghi V, Rusconi S, Saracino A, Gennari W, Bruzzone B, Vicenti I, Callegaro A, Di Biagio A, Zazzi M, Di Giambenedetto S, Borghetti A. Salvo PF, et al. Among authors: di giambenedetto s. Viruses. 2023 Mar 16;15(3):762. doi: 10.3390/v15030762. Viruses. 2023. PMID: 36992471 Free PMC article.
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
Kabra M, Barber TJ, Allavena C, Marcelin AG, Di Giambenedetto S, Pasquau J, Gianotti N, Llibre JM, Rial-Crestelo D, De Miguel-Buckley R, Blick G, Turner M, Harrison C, Wynne T, Verdier G, Parry CM, Jones B, Okoli C, Donovan C, Priest J, Letang E. Kabra M, et al. Among authors: di giambenedetto s. Open Forum Infect Dis. 2023 Oct 27;10(11):ofad526. doi: 10.1093/ofid/ofad526. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38033982 Free PMC article.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
Lagi F, Giacomelli A, Borghi V, Ciccullo A, Taramasso L, Madeddu G, D'Ettorre G, Giacometti A, Ducci F, De Vito A, Pincino R, Di Giambenedetto S, Mussini C, Antinori S, Sterrantino G. Lagi F, et al. Among authors: di giambenedetto s. J Med Virol. 2023 Oct;95(10):e29149. doi: 10.1002/jmv.29149. J Med Virol. 2023. PMID: 37805832
232 results